|Bid||0.1200 x 0|
|Ask||0.1300 x 0|
|Day's Range||0.1200 - 0.1300|
|52 Week Range||0.0450 - 0.2400|
|Beta (5Y Monthly)||0.92|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") published a notice of meeting and record date for the upcoming special meeting of shareholders of MYM (the "Meeting") disclosing that the record date will be May 31, 2021 and the Meeting will be on July 5, 2021. At the Meeting, shareholders will be asked to consider and vote on a special resolution approving, among ...
Toronto, Ontario--(Newsfile Corp. - May 21, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) ("MYM" or the "Company"): This press release is being disseminated by Cultivator Catalyst Corp. (the "Acquiror") as required by National Instrument 62-103 The Early Warning System and Related Take-Over Bids and Insider Reporting Issues in connection with its acquisition of securities of MYM.Effective May 21, 2021, the Acquiror acquired 88,904,428 Common Shares in the capital of the Company, pursuant to a ...
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") today announced its financial results for the three-month period ending February 28, 2021 ("Q3 2021"). The Company's Financial Statements and Management Discussion & Analysis ("MD&A") are available on sedar.com. Key Highlights for Q3 2021Gross revenue of $4.4 million, an increase of 8% from the prior quarterPositive EBITDA of $212,628Expanded distribution to three new ...